封面
市场调查报告书
商品编码
1820101

2025-2033 年宏基因体学市场报告(按产品、技术、应用和地区)

Metagenomics Market Report by Product, Technology, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球宏基因体学市场规模达 6.191 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 14.541 亿美元,2025-2033 年期间的成长率 (CAGR) 为 9.45%。

宏基因体学是指对自然环境中微生物基因组的研究。它透过克隆基因组来研究其生态学、进化和多样性,从而避免了对单一物种进行分离和实验室培养的需要。宏基因体学利用定序和生物资讯技术来获取科学见解,并作为分子工具,用于分析从水、土壤和人类排泄物等环境样本中获取的脱氧核糖核酸 (DNA)。这些样本会透过序列读取、基因预测、分箱和功能註释进行进一步处理。这些见解可用于诊断传染病、环境修復、肠道微生物表征和生物燃料的开发。

宏基因体学市场趋势:

在全球范围内,腹泻、流感、B型肝炎和爱滋病毒/爱滋病等病毒性感染的日益普及是推动市场成长的关键因素之一。此外,对及时诊断脑膜炎和脑炎等神经感染性疾病的有效解决方案的需求不断增长,也为市场成长提供了动力。同时,宏基因体学也有助于识别可能导致食源性疾病爆发的细菌病原体,这进一步促进了市场的成长。与传统技术相比,宏基因组学所需的预测序步骤更少,提高了长序列读取的真实性,并提供了更高的读取准确率。此外,各种技术进步,例如下一代定序服务的开发,也是其他促进成长的因素。这些解决方案与资料分析软体集成,可加快资料分析和样本处理速度。其他因素,包括生命科学领域的广泛研究和开发 (R&D) 活动,以及越来越多地利用宏基因组学来製造永续农产品,预计将推动市场成长。

本报告回答的关键问题:

  • 全球宏基因体学市场迄今表现如何?未来几年将如何表现?
  • COVID-19 对全球宏基因体学市场有何影响?
  • 主要的区域市场有哪些?
  • 根据产品,市场是如何分類的?
  • 基于技术的市场区隔是怎样的?
  • 根据应用,市场是如何分類的?
  • 该产业的价值链分为哪些阶段?
  • 该行业的主要驱动因素和挑战是什么?
  • 全球宏基因体学市场的结构是怎么样的?主要参与者是谁?
  • 产业竞争程度如何?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:简介

第五章:全球宏基因体学市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章:市场区隔:依产品

  • 仪器和软体
  • 耗材

第七章:市场区隔:依技术

  • 定序
  • 生物资讯学

第 8 章:市场区隔:按应用

  • 传染病诊断
  • 环境修復
  • 肠道微生物特征
  • 生物技术
  • 生物燃料
  • 农业

第九章:市场细分:依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章:SWOT 分析

第 11 章:价值链分析

第 12 章:波特五力分析

第十三章:价格分析

第 14 章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Enterome
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG (Roche Holding AG)
    • Illumina Inc
    • Novogene Co. Ltd.
    • Oxford Nanopore Technologies Limited
    • Pacific Biosciences of California Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Swift Biosciences Inc. (Danaher Corporation)
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4344

The global metagenomics market size reached USD 619.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,454.1 Million by 2033, exhibiting a growth rate (CAGR) of 9.45% during 2025-2033.

Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.

Metagenomics Market Trends:

The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

  • Instruments and Software
  • Consumables

Breakup by Technology:

  • Sequencing
  • Bioinformatics

Breakup by Application:

  • Infectious Disease Diagnosis
  • Environmental Remediation
  • Gut Microbe Characterization
  • Biotechnology
  • Biofuel
  • Agriculture

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global metagenomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global metagenomics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metagenomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metagenomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments and Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Sequencing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Environmental Remediation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Gut Microbe Characterization
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Biotechnology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Biofuel
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Agriculture
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Enterome
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Eurofins Scientific
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Illumina Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Novogene Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oxford Nanopore Technologies Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pacific Biosciences of California Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 PerkinElmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN N.V.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Swift Biosciences Inc. (Danaher Corporation)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Metagenomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metagenomics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Metagenomics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Metagenomics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Metagenomics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Metagenomics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Metagenomics (Instruments and Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Metagenomics (Instruments and Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Metagenomics (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Metagenomics (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Metagenomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Metagenomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Metagenomics (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Metagenomics (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Metagenomics (Infectious Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Metagenomics (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Metagenomics (Environmental Remediation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Metagenomics (Environmental Remediation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Metagenomics (Gut Microbe Characterization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Metagenomics (Gut Microbe Characterization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Metagenomics (Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Metagenomics (Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Metagenomics (Biofuel) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Metagenomics (Biofuel) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Metagenomics (Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Metagenomics (Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Metagenomics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Metagenomics Industry: SWOT Analysis
  • Figure 78: Global: Metagenomics Industry: Value Chain Analysis
  • Figure 79: Global: Metagenomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metagenomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Metagenomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Metagenomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Metagenomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Metagenomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Metagenomics Market: Competitive Structure
  • Table 7: Global: Metagenomics Market: Key Players